WHERE REGULATORY LEADERSHIP MEETS SCIENTIFIC INSIGHT
RCSS is an independent regulatory consultancy led by Dr. Nathalie Machluf, a former VP of Regulatory Affairs with extensive experience in global drug development across biological and pharmaceutical products.
RCSS provides executive-level regulatory leadership across CMC, clinical, and submission strategy, supporting biotech and pharmaceutical companies throughout the full product lifecycle — from early clinical development through global registration and post-approval.
By combining deep scientific expertise with strategic regulatory leadership, RCSS helps companies navigate complex regulatory pathways with clarity, mitigate development risks, and advance innovative products efficiently and successfully.
WHY RCSS?
-
Executive-Level Expertise: Direct access to a former VP of Regulatory Affairs with global experience in biologics and pharmaceuticals.
-
Strategic Guidance Across the Lifecycle: From early clinical development to post-approval, RCSS provides leadership in regulatory, CMC, non-clinical, clinical and submission strategy.
-
Risk Mitigation & Efficiency: Navigate complex regulatory pathways with clarity, avoid common pitfalls, and accelerate product development.
-
Tailored, High-Impact Support: Hands-on involvement in critical submissions, reviews, and strategic decision-making whenever needed.
ONE GOAL
YOUR SUCCESS
Behind every milestone lies a greater purpose: bringing innovative treatments to patients with unmet medical needs and offering hope where treatment options remain limited.
As a passionate scientist, I’m deeply driven by the potential of innovation to transform patients’ lives. I thrive on tackling complex challenges, connecting scientific insight with critical thinking to find practical, effective solutions. I bring this mindset to every project, balancing scientific ambition with real-world time, budget, and resource constraints.